Diagnosing tuberculosis
105 results
1 - 100
Diagnosing tuberculosis
Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV‐positive individuals
Exposure to tuberculous infection
Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis
Parallel use of low‐complexity automated nucleic acid amplification tests on respiratory and stool samples with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children
Allergic alveolitis
Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
Length of tuberculosis chemotherapy
Low‐complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescents
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
Vaccines in alphabetical order
Rapid diagnostic tests for the detection of tuberculosis
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV
Eye symptoms and signs of systemic diseases
Interventions to increase tuberculosis case detection at primary healthcare or community‐level services
Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV
Screening tests for active pulmonary tuberculosis in children
Fixed‐dose combinations of drugs versus single‐drug formulations for treating pulmonary tuberculosis
Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views
BCG vaccine
Undernutrition as a risk factor for tuberculosis disease
Routine surgery in addition to chemotherapy for treating spinal tuberculosis
Low‐complexity manual nucleic acid amplification tests for pulmonary tuberculosis in children
Active case finding in contacts of people with tuberculosis
Diabetes as a risk factor for tuberculosis disease
Parallel use of low‐complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV
Pneumonia
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
Pleural effusions and thoracentesis
Truenat MTB assays for pulmonary tuberculosis and rifampicin resistance in adults and adolescents
Symptom‐ and chest‐radiography screening for active pulmonary tuberculosis in HIV‐negative adults and adults with unknown HIV status
Vasculitides
Prolonged fever of unknown origin in children
Air travel and illness
Haemoptysis
Intermittent versus daily therapy for treating tuberculosis in children: Cochrane systematic review
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
Myositis
Prolonged cough in adults
Elevated ESR (hypersedimentation)
Erythema nodosum
Excessive sweating (hyperhidrosis)
HIV infection
Meningitis in children
High-risk work with regard to communicable diseases
Vaccinations
Prolonged cough in a child
Isoniazid for preventing tuberculosis in HIV‐infected children
Impaired vision
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
Deep hand infections
Unintentional weight loss in adults
Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old: Cochrane systematic review
Fever in a returning traveller
Urinalysis and bacterial culture
Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy: Cochrane systematic review
Prolonged diarrhoea in adults
Corticosteroids for managing tuberculous meningitis
Rheumatoid arthritis
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults
Digital contact tracing technologies in epidemics: a rapid review

